HICON (Jubilant DraxImage Inc.)


Welcome to the PulseAid listing for the HICON drug offered from Jubilant DraxImage Inc.. This Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Jubilant DraxImage Inc.
NON-PROPRIETARY NAME: Sodium Iodide I 131
SUBSTANCE NAME: SODIUM IODIDE I-131
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radioactive Therapeutic Agent [EPC],Radiopharmaceutical Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-04-07
END MARKETING DATE: 0000-00-00


HICON HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHICON from Jubilant DraxImage Inc.
LABELER NAME: Jubilant DraxImage Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mCi/mL)
START MARKETING DATE: 2003-04-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65174-880_a3c600a0-7411-476d-a486-4153ff25420d
PRODUCT NDC: 65174-880
APPLICATION NUMBER: NDA021305

Other SODIUM IODIDE I-131 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth CorporationI 131 Mini
International Isotopes IncSodium Iodide I-131
Jubilant DraxImage Inc.Sodium Iodide I 131 Diagnostic
MALLINCKRODT NUCLEAR MEDICINE LLCSodium Iodide I-131